6.36B-parameter cancer genomics transformer
Precision cancer therapy, grounded in evidence
Quark predicts drug response from genomic mutations with a 6.36B-parameter transformer. 100% cancer-type accuracy and 96.15% drug-response accuracy, calibrated against 1,227 CIViC clinical-evidence entries.
6.36B
Model parameters
100%
Cancer-type accuracy
96.15%
Drug-response accuracy
1,227
CIViC evidence entries
Platform capabilities
One focused workflow from mutation profile to evidence-backed therapy ranking.
Genomic response prediction
Predict sensitivity, resistance, survival and combination response from a mutation profile.
Clinical evidence
See when CIViC evidence changes a prediction, including evidence level and blend weight.
Therapy ranking
Compare candidate therapies for the same mutation profile with calibrated confidence.
Drug safety
Check known drug interactions alongside model results before exporting a research report.
Built with
PyTorch FSDPAzure MLNext.js 15 / React 19FastAPICUDA 12.6CIViCTypeScript